» Articles » PMID: 36102060

Functions of Exogenous FGF Signals in Regulation of Fibroblast to Myofibroblast Differentiation and Extracellular Matrix Protein Expression

Overview
Journal Open Biol
Date 2022 Sep 14
PMID 36102060
Authors
Affiliations
Soon will be listed here.
Abstract

Fibroblasts are widely distributed cells found in most tissues and upon tissue injury, they are able to differentiate into myofibroblasts, which express abundant extracellular matrix (ECM) proteins. Overexpression and unordered organization of ECM proteins cause tissue fibrosis in damaged tissue. Fibroblast growth factor (FGF) family proteins are well known to promote angiogenesis and tissue repair, but their activities in fibroblast differentiation and fibrosis have not been systematically reviewed. Here we summarize the effects of FGFs in fibroblast to myofibroblast differentiation and ECM protein expression and discuss the underlying potential regulatory mechanisms, to provide a basis for the clinical application of recombinant FGF protein drugs in treatment of tissue damage.

Citing Articles

One-pot synthesis and pharmacological evaluation of new quinoline/pyrimido-diazepines as pulmonary antifibrotic agents.

Fawzy M, Ibrahim K, Aly A, Mohamed A, Abdel Hafez S, Abdelzaher W Future Med Chem. 2024; 16(21):2211-2230.

PMID: 39291539 PMC: 11622787. DOI: 10.1080/17568919.2024.2394018.


Structural and biochemical investigation into stable FGF2 mutants with novel mutation sites and hydrophobic replacements for surface-exposed cysteines.

An Y, Jung Y, Lee K, Kaushal P, Ko I, Shin S PLoS One. 2024; 19(9):e0307499.

PMID: 39236042 PMC: 11376533. DOI: 10.1371/journal.pone.0307499.


4-aminopyridine attenuates inflammation and apoptosis and increases angiogenesis to promote skin regeneration following a burn injury.

Govindappa P, V G R, Ellur G, A Gaber A, Elfar J Res Sq. 2024; .

PMID: 39149501 PMC: 11326401. DOI: 10.21203/rs.3.rs-4669610/v1.


Production of recombinant human epidermal growth factor fused with HaloTag protein and characterisation of its biological functions.

Bai M, Liu Y, Liu H, Jia Y, Tian X, Sun C PeerJ. 2024; 12:e17806.

PMID: 39035165 PMC: 11259126. DOI: 10.7717/peerj.17806.


Immunohistochemical-properties of the dermal embryonic telocytes.

Soliman S Sci Rep. 2024; 14(1):13899.

PMID: 38886354 PMC: 11183069. DOI: 10.1038/s41598-024-63802-5.


References
1.
Matsuoka H, Arai T, Mori M, Goya S, Kida H, Morishita H . A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2002; 283(1):L103-12. DOI: 10.1152/ajplung.00187.2001. View

2.
Xu R, Ori A, Rudd T, Uniewicz K, Ahmed Y, Guimond S . Diversification of the structural determinants of fibroblast growth factor-heparin interactions: implications for binding specificity. J Biol Chem. 2012; 287(47):40061-73. PMC: 3501079. DOI: 10.1074/jbc.M112.398826. View

3.
Honda E, Park A, Yoshida K, Tabuchi M, Munakata H . Myofibroblasts: Biochemical and proteomic approaches to fibrosis. Tohoku J Exp Med. 2013; 230(2):67-73. DOI: 10.1620/tjem.230.67. View

4.
Zaman P, Wang J, Blau A, Wang W, Li T, Kohane D . Incorporation of heparin-binding proteins into preformed dextran sulfate-chitosan nanoparticles. Int J Nanomedicine. 2016; 11:6149-6159. PMC: 5125769. DOI: 10.2147/IJN.S119174. View

5.
Wiedemann M, Trueb B . Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors. Genomics. 2000; 69(2):275-9. DOI: 10.1006/geno.2000.6332. View